IMMU-16. ANTI-VEGF TREATMENT EFFECT AGAINST GLIOMA IS IMMUNE DEPENDENT AND MEDIATED BY ENHANCED T CELL ACTIVITY
Cécile L. Maire(Dana-Farber Cancer Institute), Katrin Lamszus(Universität Hamburg), Michael Spohn(Centre Hospitalier Universitaire de Clermont-Ferrand), Sarina Heinemann(Universität Hamburg), Malte Mohme(Universität Hamburg), Manfred Westphal(Universität Hamburg), Jens Gempt(TUM Klinikum), Christian Casar(Universität Hamburg), Malik Alawi(Universität Hamburg), Eva Tolosa(Universitat Autònoma de Barcelona), Merle Reetz(Universität Hamburg), Krystian Fita(Universität Hamburg)
Cited by 1
Related Papers
Pan-cancer analysis of whole genomes
|Nature|2020|3.3k
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles
|Science Advances|2018|614
Comprehensive molecular characterization of mitochondrial genomes in human cancers
|Nature Genetics|2020|520